Rodgers Brothers’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.56M Sell
17,266
-1,850
-10% -$170K 0.18% 118
2025
Q4
$1.72M Sell
19,116
-3,000
-14% -$284K 0.21% 106
2025
Q3
$2.18M Sell
22,116
-7,575
-26% -$751K 0.27% 98
2025
Q2
$2.71M Sell
29,691
-4,650
-14% -$450K 0.34% 85
2025
Q1
$3.89M Sell
34,341
-3,610
-10% -$386K 0.52% 56
2024
Q4
$4.01M Sell
37,951
-1,315
-3% -$141K 0.52% 59
2024
Q3
$4.24M Buy
39,266
+50
+0.1% +$5.46K 0.54% 58
2024
Q2
$4.26M Sell
39,216
-625
-2% -$73.7K 0.58% 52
2024
Q1
$5.26M Hold
39,841
0.72% 44
2023
Q4
$4.85M Sell
39,841
-100
-0.3% -$11.2K 0.77% 42
2023
Q3
$4.48M Buy
39,941
+1,025
+3% +$130K 0.77% 49
2023
Q2
$5.67M Buy
38,916
+165
+0.4% +$22.4K 1% 31
2023
Q1
$5.01M Sell
38,751
-1,250
-3% -$157K 0.96% 32
2022
Q4
$5.1M Buy
40,001
+110
+0.3% +$12.8K 1.03% 30
2022
Q3
$4.17M Buy
39,891
+175
+0.4% +$19.2K 0.89% 35
2022
Q2
$4.17M Buy
39,716
+2,500
+7% +$297K 0.82% 36
2022
Q1
$4.76M Buy
37,216
+32,925
+767% +$3.97M 0.85% 35
2021
Q4
$529K Buy
+4,291
New +$562K 0.09% 161

Other funds holding ZBH

Rodgers Brothers's ZBH Position: Q1 2026 in Review

Rodgers Brothers reduced its Zimmer Biomet (ZBH) stake by 9.7% in Q1 2026, selling an estimated $170K and leaving 17,266 shares worth $1.56M. The position accounts for 0.18% of the portfolio, ranked #118.

Rodgers Brothers first reported a position in ZBH in Q4 2021 and has held it in 18 quarters since. The position peaked at $5.67M in Q2 2023. 913 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Rodgers Brothers held 17,266 shares of Zimmer Biomet worth $1.56M as of Q1 2026.
  • Rodgers Brothers sold 1,850 Zimmer Biomet shares in Q1 2026, an estimated $170K.
  • Zimmer Biomet made up 0.18% of Rodgers Brothers's portfolio in Q1 2026, its #118 holding.
  • Rodgers Brothers first reported a position in Zimmer Biomet in Q4 2021 and has held it in 18 quarters since.
  • Rodgers Brothers's Zimmer Biomet position peaked at $5.67M in Q2 2023.
  • 913 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Rodgers Brothers's 13F filing for Q1 2026, filed 14 May 2026.